Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell CarcinomaTarek Mekhail, Ronald M. Bukowski|Journal of Clinical Oncology|2005Cited by 571
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoidRonald M. Bukowski, John J. Rinehart, Harmon J. Eyre et al.|Cancer|1994Cited by 89
T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.Xiaoli Li, James H. Finke, Jun Liu et al.|PubMed|1994Cited by 84
Impaired Signal Transduction in Tumor Infiltrating T Cells from Patients with Renal Cell CarcinomaJames H. Finke, Ronald M. Bukowski, Seiji Kudoh et al.|Unknown|1995Cited by 1